MED ' OUINDI
0847.343.894 · rovalta.com · 25/09/2026
MED ' OUINDI
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBOMED ' OUINDI is a Private limited company incorporated in 2012. Its main activity is: General medical practice activities. Its registered office is in Etterbeek.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0847.343.894
- Incorporation
- 12/07/2012
- Legal form
- Private limited company
- Registered office
- Rue Philippe Baucq 83
1040 Etterbeek · BruxellesSee on map - Contributed capital
- 1,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 209 k € | +5.5% | 198,1 k € | +45.5% | 136,2 k € | -32.6% | 202,1 k € | -30.2% | 289,7 k € |
| EBITDA | 184,1 k € | +21.0% | 152,2 k € | +75.4% | 86,7 k € | -45.7% | 159,8 k € | -35.9% | 249,3 k € |
| Operating result | 148,8 k € | +35.6% | 109,8 k € | +94.4% | 56,5 k € | -52.8% | 119,7 k € | -34.6% | 183,2 k € |
| Net result | 101,3 k € | +45.7% | 69,5 k € | +104% | 34,1 k € | -62.5% | 90,9 k € | -32.2% | 134,1 k € |
| Balance sheet | |||||||||
| Equity | 625,9 k € | +4.6% | 598,4 k € | +13.1% | 528,9 k € | -8.1% | 575,5 k € | +13.1% | 508,9 k € |
| Total assets | 756,2 k € | +10.7% | 683,2 k € | +1.2% | 675,1 k € | -12.6% | 772,1 k € | +1.3% | 762,3 k € |
| Cash | 125,6 k € | +109% | 60,1 k € | +45.2% | 41,4 k € | -58.4% | 99,4 k € | +3.5% | 96,1 k € |
| Debts | 130,1 k € | +53.5% | 84,8 k € | -42.0% | 146,1 k € | -25.7% | 196,6 k € | -22.4% | 253,2 k € |
| Other | |||||||||
| Workforce | – | – | 1,9 ETP | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Abridged model | Micro model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/06/2026 | 19/05/2025 | 30/05/2024 | 25/05/2023 | 31/05/2022 | 20/05/2021 |
| General meeting | 06/06/2026 | 28/03/2025 | 30/04/2024 | 31/03/2023 | 25/03/2022 | 26/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 06/06/2026 | 06/06/2026 | French | |
| Micro model | 30/09/2024 | 28/03/2025 | 19/05/2025 | French | |
| Abridged model | 30/09/2023 | 30/04/2024 | 30/05/2024 | French | |
| Micro model | 30/09/2022 | 31/03/2023 | 25/05/2023 | French | |
| Abridged model | 30/09/2021 | 25/03/2022 | 31/05/2022 | French | |
| Abridged model | 30/09/2020 | 26/03/2021 | 20/05/2021 | French | |
| Abridged model | 30/09/2019 | 18/05/2020 | 28/05/2020 | French | |
| Abridged model | 30/09/2018 | 29/03/2019 | 21/05/2019 | French | |
| Abridged model | 30/09/2017 | 30/03/2018 | 30/05/2018 | French | |
| Abridged model | 30/09/2016 | 31/03/2017 | 15/05/2017 | French | |
| Abridged model | 30/09/2015 | 20/03/2016 | 28/03/2016 | French | |
| Abridged model | 30/09/2014 | 05/03/2015 | 30/03/2015 | French | |
| Abridged model | 30/09/2013 | 26/03/2014 | 05/05/2014 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025101,3 k €↑
- 2024Annual accounts 202469,5 k €↑
- 2023Annual accounts 202334,1 k €↓
- 2022Annual accounts 202290,9 k €↓
- 2021Annual accounts 2021134,1 k €↑
- 2020Annual accounts 202029 k €↓
- 2019Annual accounts 201966,1 k €↑
- 2018Annual accounts 2018-10,7 k €↓
- 2017Annual accounts 2017165,7 k €↑
- 2016Annual accounts 201648,8 k €↓
- 2015Annual accounts 201576,9 k €↑
- 2014Annual accounts 201458,4 k €↓
- 2013Annual accounts 201376,9 k €
- 12/07/2012IncorporationPrivate limited company